“…[5] Despite these tremendous advances,t he known synthetic methods still suffer from various problems,such as:1)high catalyst loading (at least 5mol %);2 )rarely using cheaper and more stable Cu II catalysts in contrast to Cu I catalysts; [6] 3) few examples of providing exo'-adducts as the major isomers; [7] 4) limited trifluomethylated starting materials. [9] Among various fluoroalkyl groups,t he trifluoromethyl group (CF 3 )h as received significant attention because of its similar size to the methyl group and its high electronegativity resulting in unique stereoelectronic properties,w hich may substantially increase the metabolic stability,l ipophilicity,a nd thus bioavailability of drug molecules.I ndeed, an umber of CF 3 -substituted pyrrolidines displaying interesting bioactivities have been reported, including the insecticide A, [10] suicide inhibitor B, [11] antibacterial agent C, [12] and hepatitis Cv irus inhibitor D [13] ( Figure 1). [9] Among various fluoroalkyl groups,t he trifluoromethyl group (CF 3 )h as received significant attention because of its similar size to the methyl group and its high electronegativity resulting in unique stereoelectronic properties,w hich may substantially increase the metabolic stability,l ipophilicity,a nd thus bioavailability of drug molecules.I ndeed, an umber of CF 3 -substituted pyrrolidines displaying interesting bioactivities have been reported, including the insecticide A, [10] suicide inhibitor B, [11] antibacterial agent C, [12] and hepatitis Cv irus inhibitor D [13] ( Figure 1).…”